| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Collegium Pharmaceutical, Inc. (COLL) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 16 sells. COLL is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 3.13M | $109.24M | - | |
| CFO | 126.7K | $4.42M | - | |
| VP | 121.2K | $4.23M | - | |
| CEO | 97.0K | $3.38M | - | |
| Dir | 95.0K | $3.31M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 7, 2019 | Ciaffoni Joseph | President And CEO | Sale+OE | 64,821 | $18.77 | $1,216,774.11 | -14.4% | |
| Aug 29, 2019 | Hirsch David | Director | Sale+OE | 22,106 | $11.65 | $257,534.90 | -34.4% | |
| Jul 15, 2019 | Heffernan Michael Thomas | Director | Sell | 25,000 | $11.26 | $281,500.00 | -15.9% | |
| Jul 11, 2019 | Dreyer Scott54 | EVP &Chief Commercial Officer | Sell | 2,857 | $12.31 | $35,169.67 | -7.0% | |
| Jun 17, 2019 | Heffernan Michael Thomas | Director | Sell | 25,000 | $11.37 | $284,245.54 | -7.3% | |
| Jun 3, 2019 | Ciaffoni Joseph | President And CEO | Sell | 13,287 | $11.56 | $153,586.76 | -3.5% | |
| May 15, 2019 | Heffernan Michael Thomas | Director | Sell | 25,000 | $12.84 | $321,041.63 | -6.3% | |
| Apr 15, 2019 | Heffernan Michael Thomas | Director | Sell | 25,000 | $15.09 | $377,365.68 | -5.8% | |
| Mar 15, 2019 | Heffernan Michael Thomas | Director | Sell | 25,000 | $17.17 | $429,250.00 | -9.9% | |
| Feb 15, 2019 | Heffernan Michael Thomas | Director | Sell | 25,000 | $14.81 | $370,223.80 | -4.7% |